Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial

AIMS/HYPOTHESIS: Consumption of excess carbohydrates to manage hypoglycaemia can lead to rebound hyperglycaemia and promote weight gain. The objective of this trial was to evaluate the efficacy, safety and feasibility of pen-administered low-dose dasiglucagon for prevention and treatment of non-seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Laugesen, Christian, Ranjan, Ajenthen G., Schmidt, Signe, Nørgaard, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244275/
https://www.ncbi.nlm.nih.gov/pubmed/37037948
http://dx.doi.org/10.1007/s00125-023-05909-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244275/
https://www.ncbi.nlm.nih.gov/pubmed/37037948
http://dx.doi.org/10.1007/s00125-023-05909-4

Ejemplares similares